Advances in Rheumatoid Arthritis Drugs
(2016)
Advances in Rheumatoid Arthritis Drugs: pp.
-.
Chapter 11
The ‘Switch’ Study Protocol: A Randomisedcontrolled Trial of Switching to an Alternative Tumour-Necrosis Factor (TNF)-Inhibitor Drug or Abatacept or Rituximab in Patients with Rheumatoid Arthritis Who Have Failed an Initial TNF-Inhibitor Drug